IRIDEX Shares Outstanding 2010-2024 | IRIX
IRIDEX shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
IRIDEX Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
16 |
| 2022 |
16 |
| 2021 |
15 |
| 2020 |
14 |
| 2019 |
14 |
| 2018 |
12 |
| 2017 |
12 |
| 2016 |
10 |
| 2015 |
10 |
| 2014 |
10 |
| 2013 |
10 |
| 2012 |
9 |
| 2011 |
10 |
| 2010 |
10 |
| 2009 |
10 |
IRIDEX Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-09-30 |
17 |
| 2024-06-30 |
16 |
| 2024-03-31 |
16 |
| 2023-12-31 |
16 |
| 2023-09-30 |
16 |
| 2023-06-30 |
16 |
| 2023-03-31 |
16 |
| 2022-12-31 |
16 |
| 2022-09-30 |
16 |
| 2022-06-30 |
16 |
| 2022-03-31 |
16 |
| 2021-12-31 |
15 |
| 2021-09-30 |
16 |
| 2021-06-30 |
16 |
| 2021-03-31 |
14 |
| 2020-12-31 |
14 |
| 2020-09-30 |
14 |
| 2020-06-30 |
14 |
| 2020-03-31 |
14 |
| 2019-12-31 |
14 |
| 2019-09-30 |
14 |
| 2019-06-30 |
14 |
| 2019-03-31 |
14 |
| 2018-12-31 |
12 |
| 2018-09-30 |
12 |
| 2018-06-30 |
12 |
| 2018-03-31 |
12 |
| 2017-12-31 |
12 |
| 2017-09-30 |
12 |
| 2017-06-30 |
12 |
| 2017-03-31 |
12 |
| 2016-12-31 |
10 |
| 2016-09-30 |
10 |
| 2016-06-30 |
10 |
| 2016-03-31 |
10 |
| 2015-12-31 |
10 |
| 2015-09-30 |
10 |
| 2015-06-30 |
10 |
| 2015-03-31 |
10 |
| 2014-12-31 |
10 |
| 2014-09-30 |
10 |
| 2014-06-30 |
10 |
| 2014-03-31 |
11 |
| 2013-12-31 |
10 |
| 2013-09-30 |
10 |
| 2013-06-30 |
10 |
| 2013-03-31 |
10 |
| 2012-12-31 |
9 |
| 2012-09-30 |
9 |
| 2012-06-30 |
10 |
| 2012-03-31 |
9 |
| 2011-12-31 |
10 |
| 2011-09-30 |
10 |
| 2011-06-30 |
10 |
| 2011-03-31 |
10 |
| 2010-12-31 |
10 |
| 2010-09-30 |
10 |
| 2010-06-30 |
10 |
| 2010-03-31 |
10 |
| 2009-12-31 |
10 |
| 2009-09-30 |
10 |
| 2009-06-30 |
10 |
| 2009-03-31 |
10 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.028B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
